SCHEMBL20587647

SCHEMBL20587647

CN(C)C(=O)c1ccc(N)nn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 3/20 0.38
PIK3CA P42336 2/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CB P42338 1/20 0.38
PI4KA P42356 1/20 0.38
PIK3CG P48736 1/20 0.38
PI4KB Q9UBF8 1/20 0.38
KDM4A O75164 1/20 0.37
LRRK2 Q5S007 1/20 0.37
NNMT P40261 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 1/20 0.34
MALT1 Q9UDY8 1/20 0.33
GABRP O00591 2/20 0.32
GABRD O14764 2/20 0.32
GABRA1 P14867 2/20 0.32
GABRB1 P18505 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18667426 0.78 KDM4A (0.38) MTORPIK3CAPIK3CDPIK3CBPI4KA
SCHEMBL30508771 0.77 KCNJ1 (0.43) NNMTSMN1; SMN2ALDH1A1GABRPGABRD
SCHEMBL5302622 0.77 KCNJ1 (0.43) NNMTSMN1; SMN2ALDH1A1GABRPGABRD
SCHEMBL18339567 0.76 JUN (0.41) PIK3CAPIK3CDPIK3CBPI4KAPIK3CG
SCHEMBL15142310 0.74 NNMT (0.61) KDM4ALRRK2NNMTSMN1; SMN2ALDH1A1
SCHEMBL2177672 0.74 GABRP (0.43) KDM4ANNMTSMN1; SMN2ALDH1A1GABRP
SCHEMBL3153355 0.74 NNMT (0.55) NNMTSMN1; SMN2ALDH1A1GABRPGABRD
SCHEMBL26421526 0.73 KDM4A (0.36) PIK3CAPIK3CDPIK3CBPI4KAPIK3CG
SCHEMBL1458173 0.72 MAPK1 (0.47) NNMTALDH1A1HPGDMAPT
SCHEMBL20588738 0.72 SCN10A (0.41) MTORPIK3CAPI4KAPI4KBNNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3638669-A1 SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES Bayer Pharma Aktiengesellschaft (DE) 2020-04-22 EP disclosed
WO-2018228920-A1 SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-12-20 WO disclosed